| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADAMTS13, lucky to have a hydrophobic pocket
|
Zheng, X. Long
|
|
|
125 |
12 |
p. 1852-1853
|
artikel
|
| 2 |
Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT
|
Feucht, Judith
|
|
|
125 |
12 |
p. 1986-1994
|
artikel
|
| 3 |
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults
|
Savona, Michael R.
|
|
|
125 |
12 |
p. 1857-1865
|
artikel
|
| 4 |
Antigenic modulation limits the effector cell mechanisms employed by type I anti-CD20 monoclonal antibodies
|
Tipton, Thomas R.W.
|
|
|
125 |
12 |
p. 1901-1909
|
artikel
|
| 5 |
DNA methylation in lymphoma: an opportunity?
|
Ansell, Stephen M.
|
|
|
125 |
12 |
p. 1848-1849
|
artikel
|
| 6 |
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
|
Arribas, Alberto J.
|
|
|
125 |
12 |
p. 1922-1931
|
artikel
|
| 7 |
Editorial Board
|
|
|
|
125 |
12 |
p. i
|
artikel
|
| 8 |
Ependymal cells in cerebrospinal fluid: a traumatic occurrence
|
Yeh, Paul
|
|
|
125 |
12 |
p. 2005
|
artikel
|
| 9 |
FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation
|
Oellerich, Thomas
|
|
|
125 |
12 |
p. 1936-1947
|
artikel
|
| 10 |
Genetics of multiple myeloma: another heterogeneity level?
|
Corre, Jill
|
|
|
125 |
12 |
p. 1870-1876
|
artikel
|
| 11 |
How I treat incidental pulmonary embolism
|
O'Connell, Casey
|
|
|
125 |
12 |
p. 1877-1882
|
artikel
|
| 12 |
Incidental pulmonary embolism
|
|
|
|
125 |
12 |
p. 2009
|
artikel
|
| 13 |
Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor
|
Liao, Zhongji
|
|
|
125 |
12 |
p. 1995-2004
|
artikel
|
| 14 |
Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2
|
Kinkel, Sarah A.
|
|
|
125 |
12 |
p. 1890-1900
|
artikel
|
| 15 |
Markel G, Mussaffi H, Ling K-L, et al. The mechanisms controlling NK cell autoreactivity in TAP2-deficient patients. Blood. 2004;103(5):1770-1778.
|
|
|
|
125 |
12 |
p. 2006
|
artikel
|
| 16 |
Minimal residual disease in myeloma by flow cytometry: independent prediction of survival benefit per log reduction
|
Rawstron, Andy C.
|
|
|
125 |
12 |
p. 1932-1935
|
artikel
|
| 17 |
Mogamulizumab: 2 birds, 1 stone
|
Wilcox, Ryan A.
|
|
|
125 |
12 |
p. 1847-1848
|
artikel
|
| 18 |
MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development
|
Sheikh, Bilal N.
|
|
|
125 |
12 |
p. 1910-1921
|
artikel
|
| 19 |
Nair N, Rincon MY, Evens H, et al. Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy. Blood. 2014;123(20):3195-3199.
|
|
|
|
125 |
12 |
p. 2007
|
artikel
|
| 20 |
PAD4-deficiency does not affect bacteremia in polymicrobial sepsis and ameliorates endotoxemic shock
|
Martinod, Kimberly
|
|
|
125 |
12 |
p. 1948-1956
|
artikel
|
| 21 |
Parmodulins inhibit thrombus formation without inducing endothelial injury caused by vorapaxar
|
Aisiku, Omozuanvbo
|
|
|
125 |
12 |
p. 1976-1985
|
artikel
|
| 22 |
PARtitioning protease signaling
|
Nieman, Marvin T.
|
|
|
125 |
12 |
p. 1853-1855
|
artikel
|
| 23 |
Phase 1/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma
|
Duvic, Madeleine
|
|
|
125 |
12 |
p. 1883-1889
|
artikel
|
| 24 |
Slupsky JR. Enhancing BCR signals at the cell membrane. Blood. 2015;125(4):586-587.
|
|
|
|
125 |
12 |
p. 2008
|
artikel
|
| 25 |
Speaking a common language in MDS/MPNs
|
Steensma, David P.
|
|
|
125 |
12 |
p. 1849-1851
|
artikel
|
| 26 |
Sp1/Sp3 transcription factors regulate hallmarks of megakaryocyte maturation and platelet formation and function
|
Meinders, Marjolein
|
|
|
125 |
12 |
p. 1957-1967
|
artikel
|
| 27 |
The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis
|
de Groot, Rens
|
|
|
125 |
12 |
p. 1968-1975
|
artikel
|
| 28 |
Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses
|
Saret, Cayla J.
|
|
|
125 |
12 |
p. 1866-1869
|
artikel
|
| 29 |
You've got to be kindlin!
|
Simon, Scott I.
|
|
|
125 |
12 |
p. 1855-1856
|
artikel
|
Tijdschrift beschrijving